Abstract
Get full access to this article
View all access options for this article.
References
1.
Grounds
M.D.
Commentary on the present state of knowledge for myoblast transfer therapy. Cell Transplant. 5 : 431 –433 ; 1996 .
2.
Guerette
B.
Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation. Cell Transplant. (in press).
3.
Gussoni
E.
Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356 : 435 –438 ; 1992 .
4.
Hoffman
E.P.
Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci. 99 : 9 –25 ; 1990 .
5.
Huard
J.
Human myoblast transplantation: Preliminary results of 4 cases. Muscle Nerve 15 : 550 –560 ; 1992 .
6.
Huard
J.
Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant. Proc. 24 : 3049 –51 ; 1992 .
7.
Huard
J.
Dystrophin-like immunoreactivity in monkey and human brain areas involved in learning and motor functions. Neurosci. Lett. 141 : 181 –186 ; 1992 .
8.
Irintchev
A.
;
Zweyer
M.
;
Wernig
A.
Cellular and molecular reactions in mouse muscles after myoblast implantation. J. Neurocytol. 24 : 319 –331 ; 1995 .
9.
Karpati
G.
Myoblast transfer in Duchenne Muscular Dystrophy. Ann. Neurol. 36 : 8 –17 ; 1993 .
10.
Labrecque
C.
;
Roy
R.
;
Tremblay
J.P.
Immune reactions after myoblast transplantation in mouse muscles. Transplant. Proc. 24 : 2889 –2892 ; 1992 .
11.
Law
P.K.
Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplant. 2 : 485 –505 ; 1993 .
12.
Law
P.K.
Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 336 : 114 –115 ; 1990 .
13.
Law
P.K.
Long-term improvement in muscle function structure and biochemistry following myoblast transfer in DMD. Acta Cardiomiol. 3 : 282 –301 ; 1991 .
14.
Mendell
J.R.
Myoblast transfer in the treatment of duchennes muscular dystrophy. N. Engl. J. Med. 333 : 832 –838 ; 1995 .
15.
Morandi
L.
Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer. Neuromusc. Disord. 5 : 291 –295 ; 1994 .
16.
Nicholson
L.V.
Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J. Neurol. Sci. 94 : 137 –146 ; 1989 .
17.
Partridge
T.A.
Myoblast transplantation. In:
Lanza
R.P.
;
Chick
W.L.
, eds. Yearbook of cell and tissue transplantation 1996/1997. The Netherlands : Kluwer Academic Publishers ; 1996 : 53 –59 .
18.
Wernig
A.
;
Irintchev
A.
“Bystander” damage of host muscle caused by implantation of MHC-compatible myogenic cells. J. Neurol. Sci. 130 : 190 –196 ; 1995 .